Trial intelligence / Profile preview

Isosorbide mononitrate for outpatient cervical ripening

IRCT20091023002624N27Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in Pregnancy prolongation and unfavorable cervix comparing Isosorbide mononitrate with Placebo (2 arms). Primary endpoints: Bishop score 48 hours after intervention, Frequency of vaginal delivery and 2 more. Started Apr 2016; status: completed.

02

Drugs

isosorbide mononitrate
03

Conditions

Pregnancy prolongationunfavorable cervix

Beyond the preview

Go deeper on IRCT20091023002624N27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20091023002624N27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call